Insider NameBuy/SellCompany NameTickerAmountShares Change
Feb 13, 2025Feb 14, 2025Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$116.86$298,923-6.67%
Feb 10, 2025Feb 12, 2025Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$118.27$115,909-2.84%
Jan 31, 2025Feb 04, 2025Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$152.87$196,136-3.78%
Aug 13, 2024Aug 15, 2024Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$150.38$2M-30.90%
Jul 16, 2024Jul 18, 2024Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$150.04$135,037-2.78%
May 14, 2024May 16, 2024Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$137.95$4M-48.76%
Feb 13, 2024Feb 15, 2024Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$132.85$179,612-4.11%
Feb 06, 2024Feb 09, 2024Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$138.73$313,530-6.94%
Jan 31, 2024Feb 03, 2024Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$140.72$180,539-4.34%
Aug 21, 2023Aug 23, 2023Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$107.39$228,958-7.29%
Feb 06, 2023Feb 09, 2023Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$102.61$3M-53.14%
Jan 31, 2023Feb 02, 2023Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$109.98$141,108-5.67%
Feb 07, 2022Feb 09, 2022Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$80.53$345,486-17.51%
Dec 01, 2021Dec 03, 2021Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$82.59$135,852-9.14%
Feb 08, 2021Feb 10, 2021Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$116.82$339,942-16.37%
Dec 01, 2020Dec 02, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$94.66$155,721-12.52%
Nov 12, 2020Nov 16, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$90.74$204,810-18.39%
Aug 05, 2020Aug 07, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$118.9$268,356-22.04%
May 07, 2020May 12, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$110.21$2M-71.59%
Apr 28, 2020Apr 30, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$102.49$178,435-22.63%
Apr 24, 2020Apr 29, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$99.52$192,467-20.09%
Feb 07, 2020Feb 12, 2020Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$103.35$209,807-26.26%
Dec 02, 2019Dec 04, 2019Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$116.33$191,360-29.80%
Dec 03, 2018Dec 06, 2018Abernethy Matt
CFO
SellNeurocrine Biosciences IncNBIX$90$106,020-37.70%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.